3 Stocks Scoring for Investors

The Biotech Banter crew is getting into the World Cup spirit, looking at foreign biotechs to see whether they're investable.

Alkermes (NASDAQ: ALKS  ) has drugs of its own but is probably most famous for its drug delivery platforms to create extended-release drugs. The biotech gets royalties from Johnson & Johnson's schizophrenia drugs, Risperdal Consta and Invega, among others.

GW Pharmaceuticals (NASDAQ: GWPH  ) is developing drugs for epilepsy and other nervous system issues using chemicals derived from marijuana. Unlike the typical medical marijuana stocks that are cashing in on the legalization of its use, GW Pharmaceuticals is really a biotech because it's running clinical trials and seeking FDA approval for its drugs.

Valeant Pharmaceuticals (NYSE: VRX  ) is a specialty pharma, most famous at the moment for trying to buy Allergan. The drug company has grown substantially over the years through acquisitions and even became a foreign company though its acquisition of Canada-based Biovail.

Watch the following video to see whether senior biotech specialist Brian Orelli and health-care analyst David Williamson give the companies a goal, raise a yellow card, or send them off with a red card.

Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 3005165, ~/Articles/ArticleHandler.aspx, 10/25/2014 11:18:46 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 16,805.41 127.51 0.76%
S&P 500 1,964.58 13.76 0.71%
NASD 4,483.72 30.92 0.69%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2014 3:59 PM
ALKS $45.91 Up +0.63 +1.39%
Alkermes, Inc. CAPS Rating: ***
GWPH $72.77 Down -0.25 -0.34%
GW Pharmaceuticals… CAPS Rating: **
VRX $129.13 Up +1.11 +0.87%
Valeant Pharmaceut… CAPS Rating: ***

Advertisement